ArticleFrontiers in immunology2026

Predicting response to immune checkpoint inhibitor plus chemotherapy in EGFR-mutant lung adenocarcinoma following first-generation TKI resistance: a multicenter deep learning study.

Shuai Qie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.